Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.90M.
ENTERPRISE VALUE (EV)
$3.90M
Enlivex Therapeutics Ltd.
Market Cap
$5.91M
Enterprise Value (EV)
$3.90M
Market Cap
$5.77M
Enterprise Value (EV)
$3.72M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Enlivex Therapeutics Ltd. (ENLV) | $5.91M | $3.90M |
| Lucyd, Inc (LUCY)vs › | $5.85M | $3.45M |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.02M | $805520.00 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | $3.72M |
| Scienture Holdings, Inc. (SCNX)vs › | $6.10M | $8.60M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | $3.26M |
| Femasys Inc. (FEMY)vs › | $6.31M | $9.66M |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.39M | $5.91M |
| Biomerica, Inc. (BMRA)vs › | $6.54M | $7.11M |
Market Cap
$5.91M
Total Debt
$0.00
Cash
$2.01M
Enterprise Value
$3.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
